Introduction of Kunming Shenghuo Pharmaceutical (Group) Co., Ltd.

Kunming Shenghuo Pharmaceutical (Group) Co., Ltd. is a national high-tech industrialization demonstration engineering enterprise listed on the main board of American Stock Exchange. It owns four wholly-owned subsidiaries: Kunming Shenghuo Pharmaceutical Co., Ltd., Kunming Shenghuo Cosmetics Co., Ltd., Kunming Shenghuo Pharmaceutical Import and Export Co., Ltd. and Kunming Shilin Shenghuo Co., Ltd. The company is committed to the deep processing, development and comprehensive utilization of the precious medicinal material Notoginseng, which is unique to Yunnan, and has formed an enterprise group integrating scientific research, production and sales with total assets of 400 million yuan. The company has won many national, provincial and municipal awards, and is a private high-tech enterprise supported by the Ministry of Science and Technology, the Ministry of Commerce, state administration of traditional chinese medicine and the provincial and municipal governments. The production base of Kunming Shenghuo Pharmaceutical Co., Ltd. passed the GMP certification of national drugs and health food in 2002. The sales organization Shenghuo Pharmaceutical Company passed GSP certification in September 2004. The company introduced two internationally advanced soft capsule production lines from the United States, with an annual output of 2 billion capsules. Shenghuo Pharmaceutical Group has now formed a reasonable product structure of three series 186 products, including medicines, cosmetics and health products, and has a number of well-known products such as "Wang Liyan" brand Xuesaitong soft capsules and 12 classic Chinese medicine series cosmetics, among which "Wang Liyan" brand Xuesaitong soft capsules have won "Yunnan Famous Trademark" and "Yunnan Famous Brand Product".